The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

William G. Ondo

Department of Neurology

Baylor College of Medicine


TX 77030



Name/email consistency: high



  • Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA. 1999 - 2011
  • Parkinson's Disease Center, Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, USA. 2000 - 2006


  1. Memantine for non-motor features of Parkinson's disease: a double-blind placebo controlled exploratory pilot trial. Ondo, W.G., Shinawi, L., Davidson, A., Lai, D. Parkinsonism Relat. Disord. (2011) [Pubmed]
  2. Tolerability and efficacy of switching from oral selegiline to Zydis selegiline in patients with Parkinson's disease. Ondo, W.G., Hunter, C., Isaacson, S.H., Silver, D.E., Stewart, R.M., Tetrud, J.W., Davidson, A. Parkinsonism Relat. Disord. (2011) [Pubmed]
  3. Comparison of orally dissolving carbidopa/levodopa (Parcopa) to conventional oral carbidopa/levodopa: A single-dose, double-blind, double-dummy, placebo-controlled, crossover trial. Ondo, W.G., Shinawi, L., Moore, S. Mov. Disord. (2010) [Pubmed]
  4. Intravenous iron dextran for severe refractory restless legs syndrome. Ondo, W.G. Sleep Med. (2010) [Pubmed]
  5. Comparison of weight gain in treatments for Tourette syndrome: tetrabenazine versus neuroleptic drugs. Ondo, W.G., Jong, D., Davis, A. J. Child Neurol. (2008) [Pubmed]
  6. Sodium oxybate for excessive daytime sleepiness in Parkinson disease: an open-label polysomnographic study. Ondo, W.G., Perkins, T., Swick, T., Hull, K.L., Jimenez, J.E., Garris, T.S., Pardi, D. Arch. Neurol. (2008) [Pubmed]
  7. Predictors of impulsivity and reward seeking behavior with dopamine agonists. Ondo, W.G., Lai, D. Parkinsonism Relat. Disord. (2008) [Pubmed]
  8. Withdrawal of visual feedback improves micrographia in Parkinson's disease. Ondo, W.G., Satija, P. Mov. Disord. (2007) [Pubmed]
  9. Zonisamide for essential tremor. Ondo, W.G. Clin. Neuropharmacol (2007) [Pubmed]
  10. Selegiline orally disintegrating tablets in patients with Parkinson disease and "wearing off" symptoms. Ondo, W.G., Sethi, K.D., Kricorian, G. Clin. Neuropharmacol (2007) [Pubmed]
  11. Animal models of restless legs syndrome. Ondo, W.G., Zhao, H.R., Le, W.D. Sleep Med. (2007) [Pubmed]
  12. Predictors of battery life for the Activa Soletra 7426 Neurostimulator. Ondo, W.G., Meilak, C., Vuong, K.D. Parkinsonism Relat. Disord. (2007) [Pubmed]
  13. VIM deep brain stimulation does not improve pre-existing restless legs syndrome in patients with essential tremor. Ondo, W. Parkinsonism Relat. Disord. (2006) [Pubmed]
  14. Essential tremor: treatment options. Ondo, W.G. Curr. Treat. Options. Neurol (2006) [Pubmed]
  15. Subthalamic deep brain stimulation in patients with a previous pallidotomy. Ondo, W.G., Silay, Y., Almaguer, M., Jankovic, J. Mov. Disord. (2006) [Pubmed]
  16. Intravenous flumazenil for Parkinson's disease: a single dose, double blind, placebo controlled, cross-over trial. Ondo, W.G., Silay, Y.S. Mov. Disord. (2006) [Pubmed]
  17. Computerized posturography balance assessment of patients with bilateral ventralis intermedius nuclei deep brain stimulation. Ondo, W.G., Almaguer, M., Cohen, H. Mov. Disord. (2006) [Pubmed]
  18. Methadone for refractory restless legs syndrome. Ondo, W.G. Mov. Disord. (2005) [Pubmed]
  19. Olfaction testing in patients with tremor-dominant Parkinson's disease: is this a distinct condition?. Ondo, W.G., Lai, D. Mov. Disord. (2005) [Pubmed]
  20. Evaluating factors that can influence spirography ratings in patients with essential tremor. Ondo, W.G., Wang, A., Thomas, M., Vuong, K.D. Parkinsonism Relat. Disord. (2005) [Pubmed]
  21. Double-blind, placebo-controlled, unforced titration parallel trial of quetiapine for dopaminergic-induced hallucinations in Parkinson's disease. Ondo, W.G., Tintner, R., Voung, K.D., Lai, D., Ringholz, G. Mov. Disord. (2005) [Pubmed]
  22. Restless legs syndrome. Ondo, W.G. Curr. Neurol. Neurosci. Rep (2005) [Pubmed]
  23. The North American survey of placement and adjustment strategies for deep brain stimulation. Ondo, W.G., Bronte-Stewart, H. Stereotact. Funct. Neurosurg (2005) [Pubmed]
  24. Restless legs syndrome. Ondo, W.G. Neurol. Clin (2005) [Pubmed]
  25. Modafinil for daytime somnolence in Parkinson's disease: double blind, placebo controlled parallel trial. Ondo, W.G., Fayle, R., Atassi, F., Jankovic, J. J. Neurol. Neurosurg. Psychiatr. (2005) [Pubmed]
  26. Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Ondo, W.G., Vuong, K.D., Derman, H.S. Cephalalgia (2004) [Pubmed]
  27. A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson's disease. Ondo, W.G., Hunter, C., Moore, W. Neurology (2004) [Pubmed]
  28. Long-term treatment of restless legs syndrome with dopamine agonists. Ondo, W., Romanyshyn, J., Vuong, K.D., Lai, D. Arch. Neurol. (2004) [Pubmed]
  29. An open-label pilot study of levetiracetam for essential tremor. Ondo, W.G., Jimenez, J.E., Vuong, K.D., Jankovic, J. Clin. Neuropharmacol (2004) [Pubmed]
  30. Flumazenil, a GABA antagonist, may improve features of Parkinson's disease. Ondo, W.G., Hunter, C. Mov. Disord. (2003) [Pubmed]
  31. Gait and balance disorders. Ondo, W. Med. Clin. North Am. (2003) [Pubmed]
  32. Hearing impairment in essential tremor. Ondo, W.G., Sutton, L., Dat Vuong, K., Lai, D., Jankovic, J. Neurology (2003) [Pubmed]
  33. Physiological assessment of paroxysmal dystonia secondary to subacute sclerosing panencephalitis. Ondo, W.G., Verma, A. Mov. Disord. (2002) [Pubmed]
  34. Exploring the relationship between Parkinson disease and restless legs syndrome. Ondo, W.G., Vuong, K.D., Jankovic, J. Arch. Neurol. (2002) [Pubmed]
  35. Tetrabenazine treatment for Huntington's disease-associated chorea. Ondo, W.G., Tintner, R., Thomas, M., Jankovic, J. Clin. Neuropharmacol (2002) [Pubmed]
  36. Thalamic deep brain stimulation: comparison between unilateral and bilateral placement. Ondo, W., Almaguer, M., Jankovic, J., Simpson, R.K. Arch. Neurol. (2001) [Pubmed]
  37. Daytime sleepiness and other sleep disorders in Parkinson's disease. Ondo, W.G., Dat Vuong, K., Khan, H., Atassi, F., Kwak, C., Jankovic, J. Neurology (2001) [Pubmed]
  38. Thalamic deep brain stimulation: effects on the nontarget limbs. Ondo, W., Dat Vuong, K., Almaguer, M., Jankovic, J., Simpson, R.K. Mov. Disord. (2001) [Pubmed]
  39. Computerized posturography analysis of progressive supranuclear palsy: a case-control comparison with Parkinson's disease and healthy controls. Ondo, W., Warrior, D., Overby, A., Calmes, J., Hendersen, N., Olson, S., Jankovic, J. Arch. Neurol. (2000) [Pubmed]
  40. Restless legs syndrome in monozygotic twins: clinical correlates. Ondo, W.G., Vuong, K.D., Wang, Q. Neurology (2000) [Pubmed]
  41. Tetrabenazine treatment for tardive dyskinesia: assessment by randomized videotape protocol. Ondo, W.G., Hanna, P.A., Jankovic, J. Am. J. Psychiatry (1999) [Pubmed]
WikiGenes - Universities